Masimo Corp (MASI)
168.80
+3.25
(+1.96%)
USD |
NASDAQ |
Jan 08, 16:00
170.09
+1.29
(+0.76%)
After-Hours: 04:52
Masimo SG&A Expense (Quarterly): 184.80M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Abbott Laboratories | 2.895B |
| AngioDynamics Inc | 35.98M |
| Boston Scientific Corp | 1.562B |
| Globus Medical Inc | 240.74M |
| Tandem Diabetes Care Inc | 99.64M |